# Validation Documentation

FDA 21 CFR Part 11 compliance requires formal validation of computer systems used in clinical trials. This directory contains validation protocols and test results.

## Validation Approach

The Clinical Diary platform follows a three-phase validation process:

### Installation Qualification (IQ)

**Purpose**: Verify the system is installed correctly with required components and configurations.

**See**: `dev-environment/IQ.md`

**Covers**:
- Software installation verification
- Tool version validation
- Configuration correctness
- Environment setup

### Operational Qualification (OQ)

**Purpose**: Verify the system operates as designed under normal conditions.

**See**: `dev-environment/OQ.md`

**Covers**:
- Functional testing
- Feature verification
- Integration testing
- Error handling

### Performance Qualification (PQ)

**Purpose**: Verify the system performs reliably in real-world scenarios.

**See**: `dev-environment/PQ.md`

**Covers**:
- Load testing
- Performance benchmarks
- End-to-end workflows
- Production readiness

## Platform Testing

**See**: `dev-environment/platform-testing-guide.md`

Comprehensive guide for running validation tests across different platforms (Linux, macOS, Windows/WSL).

## Validation Lifecycle

1. **Development**: Run IQ/OQ tests during development
2. **Staging**: Run full IQ/OQ/PQ suite before deployment
3. **Production**: Run PQ tests after deployment
4. **Regression**: Re-run validation after significant changes

## Compliance

This validation approach satisfies:
- FDA 21 CFR Part 11 § 11.10(a) - System Validation
- ICH Q7 Guidelines - Computer Systems
- GAMP 5 Guidelines - Software Validation

## References

- **FDA Guidance**: [Computerized Systems Used in Clinical Investigations](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/computerized-systems-used-clinical-investigations)
- **Requirements**: `spec/prd-clinical-trials.md`
- **Test Infrastructure**: `database/migrations/README.md`
